July 9 (Reuters) - Integragen SA ALINT.PA :
* AGREEMENT TO FILE A FRIENDLY TAKEOVER BID INITIATED BY ONCODNA ON INTEGRAGEN TO ACQUIRE
ALL
OUTSTANDING SHARES AT A PRICE OF 2.20€ PER SHARE
* PRICE PER SHARE OF EUR 2.20, VALUING INTEGRAGEN SHARE CAPITAL AT EUR 14.5M FOR 100%
* THIS TRANSACTION REPRESENTS A PREMIUM OF +36.2% COMPARED TO LAST CLOSING PRICE OF
INTEGRAGEN
SHARES
* OFFER WAS APPROVED ON A UNANIMOUS BASIS BY ALL MEMBERS OF BOARD OF BOTH COMPANIES.
* ONCODNA IS ADVISED BY ODDO BHF, WHITE & CASE AND OSBORNE CLARKE
* INTEGRAGEN IS ADVISED BY PORTZAMPARC AND JONES DAYS.
* PUBLIC OFFER SHALL BE OPENED AT END OF Q3 OF 2020
* ONCODNA CURRENTLY OWNS NO SHARE OF INTEGRAGEN
Source text for Eikon: ID:nBw7xr487a
Further company coverage: ALINT.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))